SPARC and Sun Pharma form licensing agreement

Q.  Sun Pharma Advanced Research Company and parent company Sun Pharma have entered into a licensing agreement for Elepsis tablets used in the treatment of which disease?
- Published on 19 Jul 16

a. Malaria
b. TB
c. Epilepsy
d. None of the above

ANSWER: Epilepsy
 
Sun Pharma Advanced Research Company and parent Sun Pharma have entered into a licensing agreement for Elepsia tablets used in the treatment of epilepsy in the US market for payment of USD 10 million.
  • According to the agreement,SPARC will license Elepsia XRTM (Levetiracetam Extended Release Tablets) in a partnership with Sun Pharma.
  • Elepsia XRTM was approved by USFDA in March 2015.

Related Content

➨ Post your comment / Share knowledge


Enter the code shown above:

(Note: If you cannot read the numbers in the above image, reload the page to generate a new one.)
▲